person · Reporting owner

FLATLEY JAY T

Disclosed activity across 7 companies

Tapewire entity: 35935
SEC CIK: 0001189130

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Denali Therapeutics Inc.DNLI · Entity 1735	Director	June 03, 2026	June 05, 2026
ILLUMINA, INC.ILMN · Entity 3137	Director	May 18, 2021	May 20, 2021
Rivian Automotive, Inc. / DERIVN · Entity 3226	Director	June 22, 2026	June 23, 2026
Senti Biosciences Holdings, Inc.DYNS · Entity 7935	Director	May 25, 2021	May 26, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Denali Therapeutics Inc.

Report date June 03, 2026 · Filed June 05, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	22,628	Reported balance After 2026-06-03 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2026-06-03 · Grant · Acquired 6,408 · Balance 22,628 F1: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2: Includes 6,408 unvested RSUs.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.66 · Expires 2036-06-03	Direct	19,226	Reported balance After 2026-06-03 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2026-06-03 · Grant · Acquired 19,226 · Balance 19,226 F4: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.
Common StockSEC Table I · non-derivative	IndirectSee footnote	336,313	Reported balance Holding disclosure · report date 2026-06-03 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 336,313 F3: The shares are held of record by The Flatley Family Trust, for which the Reporting Person serves as a trustee.

Filing footnotes · ownership attribution and instrument terms

F1: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2: Includes 6,408 unvested RSUs.

F3: The shares are held of record by The Flatley Family Trust, for which the Reporting Person serves as a trustee.

F4: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

ILLUMINA, INC.

Report date May 18, 2021 · Filed May 20, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	148,933	Reported balance After 2021-05-18 transaction · row 1 1 source row Row 1 · 2021-05-18 · Sale · Disposed 4,000 · Balance 148,933 F1: The sale was made pursuant to a 10b5-1 plan.
Common StockSEC Table I · non-derivative	IndirectBy Daughters	3,500	Reported balance Holding disclosure · report date 2021-05-18 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 3,500

Filing footnotes · ownership attribution and instrument terms

F1: The sale was made pursuant to a 10b5-1 plan.

Rivian Automotive, Inc. / DE

Report date June 22, 2026 · Filed June 23, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	179,515	Reported balance After 2026-06-22 transaction · row 1 1 source row Row 1 · 2026-06-22 · Grant · Acquired 17,445 · Balance 179,515 F1: Represents an award of 17,445 restricted stock units ("RSUs") which will vest on the first anniversary of the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of 17,445 restricted stock units ("RSUs") which will vest on the first anniversary of the grant date.

Senti Biosciences Holdings, Inc.

Report date May 25, 2021 · Filed May 26, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A common stockSEC Table I · non-derivative	IndirectSee footnote	10,733	Reported balance Holding disclosure · report date 2021-05-25 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 10,733 F1: Up to 900 of these shares of Class A common stock will be forfeited in the event the underwriters for the Issuer's initial public offering do not exercise in full their overallotment option in connection with that offering, all as described in the Issuer's prospectus on Form S-1 filed on May 7, 2021 (the "Prospectus"). F2: Dynamics Sponsor LLC, a Delaware limited liability company, (the "Sponsor") is the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi who hold an economic interest therein. Any action by the Sponsor with respect to Issuer or the shares reported above, including voting and dispositive decisions, requires unanimous approval of the managers.
Class B common stockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	IndirectSee footnote	Not disclosed	Reported balance Holding disclosure · report date 2021-05-25 · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · Balance Not disclosed F3: These shares of Class B common stock will automatically convert on a one-for-one basis (subject to adjustment) into Class A common stock for no additional consideration at the time of the initial business combination by the Issuer, subject to the adjustments described in the Prospectus. The shares of Class B Common Stock have no expiration date. F4: Up to 4,894 of these shares of Class B common stock will be forfeited in the event the underwriters for the Issuer's initial public offering do not exercise in full their overallotment option in connection with that offering, all as described in the Prospectus. F2: Dynamics Sponsor LLC, a Delaware limited liability company, (the "Sponsor") is the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi who hold an economic interest therein. Any action by the Sponsor with respect to Issuer or the shares reported above, including voting and dispositive decisions, requires unanimous approval of the managers.

Filing footnotes · ownership attribution and instrument terms

F1: Up to 900 of these shares of Class A common stock will be forfeited in the event the underwriters for the Issuer's initial public offering do not exercise in full their overallotment option in connection with that offering, all as described in the Issuer's prospectus on Form S-1 filed on May 7, 2021 (the "Prospectus").

F2: Dynamics Sponsor LLC, a Delaware limited liability company, (the "Sponsor") is the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi who hold an economic interest therein. Any action by the Sponsor with respect to Issuer or the shares reported above, including voting and dispositive decisions, requires unanimous approval of the managers.

F3: These shares of Class B common stock will automatically convert on a one-for-one basis (subject to adjustment) into Class A common stock for no additional consideration at the time of the initial business combination by the Issuer, subject to the adjustments described in the Prospectus. The shares of Class B Common Stock have no expiration date.

F4: Up to 4,894 of these shares of Class B common stock will be forfeited in the event the underwriters for the Issuer's initial public offering do not exercise in full their overallotment option in connection with that offering, all as described in the Prospectus.

Past disclosures · reporting ended (3)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

COHERENT INC

Report date July 01, 2022 · Filed July 01, 2022

Section 16 reporting ended · disclosed 2022-07-01. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Family Trust	0	Reported balance After 2022-07-01 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2022-07-01 · Disposition to issuer · Disposed 43,018 · Balance 0 F1: On July 1, 2022, II-VI Incorporated ("Buyer"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Watson Merger Sub Inc, a direct, wholly owned subsidiary of Buyer ("Merger Sub"), dated as of March 25, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger (the "Merger"). F2: At the effective time of the Merger (the "Effective Time"), each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $220.00 in cash, without interest (the "Cash Consideration"), plus 0.91 of a validly issued, fully paid and nonassessable share of Buyer (the "Merger Consideration").

Filing footnotes · ownership attribution and instrument terms

F1: On July 1, 2022, II-VI Incorporated ("Buyer"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Watson Merger Sub Inc, a direct, wholly owned subsidiary of Buyer ("Merger Sub"), dated as of March 25, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger (the "Merger").

F2: At the effective time of the Merger (the "Effective Time"), each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $220.00 in cash, without interest (the "Cash Consideration"), plus 0.91 of a validly issued, fully paid and nonassessable share of Buyer (the "Merger Consideration").

Juno Therapeutics, Inc.

Report date March 05, 2018 · Filed March 07, 2018

Section 16 reporting ended · disclosed 2018-03-07. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy the Flatley Family Trust	Reported balance After 2018-03-05 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2018-03-05 · Other · Disposed 31,500 · Balance 0 F1: On January 21, 2018, Juno Therapeutics, Inc. (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Celgene Corporation ("Parent"), and Blue Magpie Corporation, a wholly owned subsidiary of Parent ("Purchaser"). On March 5, 2018, Purchaser irrevocably accepted for payment and promptly paid for, all shares of common stock validly tendered and not validly withdrawn pursuant to the Offer (as defined in the Merger Agreement). On March 6, 2018, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the "Merger") and becoming a wholly-owned subsidiary of Parent. F2: Pursuant to the terms of the Merger Agreement and the Offer, each share of common stock of the Company held by the Reporting Person was validly tendered for $87.00 per share in cash, without interest and subject to withholding of taxes.
Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.07 · Expires 2027-05-21	Direct	Reported balance After 2018-03-05 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2018-03-05 · Disposition to issuer · Disposed 18,000 · Balance 0 F1: On January 21, 2018, Juno Therapeutics, Inc. (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Celgene Corporation ("Parent"), and Blue Magpie Corporation, a wholly owned subsidiary of Parent ("Purchaser"). On March 5, 2018, Purchaser irrevocably accepted for payment and promptly paid for, all shares of common stock validly tendered and not validly withdrawn pursuant to the Offer (as defined in the Merger Agreement). On March 6, 2018, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the "Merger") and becoming a wholly-owned subsidiary of Parent. F3: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price.
Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.29 · Expires 2027-06-15	Direct	Reported balance After 2018-03-05 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2018-03-05 · Disposition to issuer · Disposed 12,000 · Balance 0 F1: On January 21, 2018, Juno Therapeutics, Inc. (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Celgene Corporation ("Parent"), and Blue Magpie Corporation, a wholly owned subsidiary of Parent ("Purchaser"). On March 5, 2018, Purchaser irrevocably accepted for payment and promptly paid for, all shares of common stock validly tendered and not validly withdrawn pursuant to the Offer (as defined in the Merger Agreement). On March 6, 2018, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the "Merger") and becoming a wholly-owned subsidiary of Parent. F3: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price.

Filing footnotes · ownership attribution and instrument terms

F1: On January 21, 2018, Juno Therapeutics, Inc. (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Celgene Corporation ("Parent"), and Blue Magpie Corporation, a wholly owned subsidiary of Parent ("Purchaser"). On March 5, 2018, Purchaser irrevocably accepted for payment and promptly paid for, all shares of common stock validly tendered and not validly withdrawn pursuant to the Offer (as defined in the Merger Agreement). On March 6, 2018, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the "Merger") and becoming a wholly-owned subsidiary of Parent.

F2: Pursuant to the terms of the Merger Agreement and the Offer, each share of common stock of the Company held by the Reporting Person was validly tendered for $87.00 per share in cash, without interest and subject to withholding of taxes.

F3: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price.

Zymergen Inc.

Report date October 19, 2022 · Filed October 20, 2022

Section 16 reporting ended · disclosed 2022-10-20. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2022-10-19 transaction · row 1 1 source row Row 1 · 2022-10-19 · Disposition to issuer · Disposed 144,789 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of July 24, 2022 (the "Merger Agreement"), by and among Ginkgo Bioworks Holdings, Inc. ("Ginkgo"), Pepper Merger Subsidiary Inc. and the Issuer, each share of the Issuer's common stock was cancelled and converted into a right to receive 0.9179 of a share of Class A common stock of Ginkgo (the "Merger Consideration"), together with cash in lieu of any fractional shares of Class A common stock of Ginkgo.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $12.33 · Expires 2031-08-06	Direct	Reported balance After 2022-10-19 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-10-19 · Disposition to issuer · Disposed 1,520,000 · Balance 0 F2: Immediately prior to the effective time of the merger (the "Effective Time"), all outstanding Issuer stock options vested in full pursuant to the terms of the agreements governing such stock options. Pursuant to the Merger Agreement, at the Effective Time, each Issuer stock option with an exercise price per share equal to or greater than the Merger Consideration Value (as defined in the Merger Agreement) was cancelled for no consideration.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $8.52 · Expires 2029-09-17	Direct	Reported balance After 2022-10-19 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2022-10-19 · Disposition to issuer · Disposed 189,125 · Balance 0 F2: Immediately prior to the effective time of the merger (the "Effective Time"), all outstanding Issuer stock options vested in full pursuant to the terms of the agreements governing such stock options. Pursuant to the Merger Agreement, at the Effective Time, each Issuer stock option with an exercise price per share equal to or greater than the Merger Consideration Value (as defined in the Merger Agreement) was cancelled for no consideration.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger, dated as of July 24, 2022 (the "Merger Agreement"), by and among Ginkgo Bioworks Holdings, Inc. ("Ginkgo"), Pepper Merger Subsidiary Inc. and the Issuer, each share of the Issuer's common stock was cancelled and converted into a right to receive 0.9179 of a share of Class A common stock of Ginkgo (the "Merger Consideration"), together with cash in lieu of any fractional shares of Class A common stock of Ginkgo.

F2: Immediately prior to the effective time of the merger (the "Effective Time"), all outstanding Issuer stock options vested in full pursuant to the terms of the agreements governing such stock options. Pursuant to the Merger Agreement, at the Effective Time, each Issuer stock option with an exercise price per share equal to or greater than the Merger Consideration Value (as defined in the Merger Agreement) was cancelled for no consideration.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
December 05, 2017 Filed Dec 8, 2017 01:21 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	4,700	$214.03	$1,005,956.04	Disclosure SEC source: 0001127602-17-034165 · form4.xml · nonDerivative · entry 4 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,217 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 4,700 shares sold ranging from $213.50 to $214.48 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
December 05, 2017 Filed Dec 8, 2017 01:21 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	4,769	$212.80	$1,014,843.68	Disclosure SEC source: 0001127602-17-034165 · form4.xml · nonDerivative · entry 3 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 497,917 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 4,769 shares sold ranging from $212.45 to $213.34 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
December 05, 2017 Filed Dec 8, 2017 01:21 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	3,294	$211.88	$697,943.26	Disclosure SEC source: 0001127602-17-034165 · form4.xml · nonDerivative · entry 2 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 502,686 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 3,294 shares sold ranging from $211.37 to $212.29 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
December 05, 2017 Filed Dec 8, 2017 01:21 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	5,737	$210.93	$1,210,097.95	Disclosure SEC source: 0001127602-17-034165 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 505,980 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 5,737 shares sold ranging from $210.37 to $211.36 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
November 21, 2017 Filed Nov 24, 2017 22:31 UTC	ILLUMINA, INC. ILMN · Entity 3137	Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative	15,000	$0.00 Strike: $70.82	$0.00	Disclosure SEC source: 0001127602-17-033236 · form4.xml · derivative · entry 6 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2021-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document
November 21, 2017 Filed Nov 24, 2017 22:31 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	5,394	$211.86	$1,142,752.88	Disclosure SEC source: 0001127602-17-033236 · form4.xml · nonDerivative · entry 4 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 511,717 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 5,394 shares sold ranging from $211.72 to $212.28 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
November 21, 2017 Filed Nov 24, 2017 22:31 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	11,501	$211.37	$2,430,934.17	Disclosure SEC source: 0001127602-17-033236 · form4.xml · nonDerivative · entry 3 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 517,111 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 11,501 shares sold ranging from $210.72 to $211.71 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
November 21, 2017 Filed Nov 24, 2017 22:31 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	3,105	$210.41	$653,335.47	Disclosure SEC source: 0001127602-17-033236 · form4.xml · nonDerivative · entry 2 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 528,612 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 3,105 shares sold ranging from $209.72 to $210.71 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
November 21, 2017 Filed Nov 24, 2017 22:31 UTC	ILLUMINA, INC. ILMN · Entity 3137	Exercise / conversionCommon Stock	15,000	$70.82	$1,062,300.00	Disclosure SEC source: 0001127602-17-033236 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 531,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document
November 16, 2017 Filed Nov 17, 2017 17:02 UTC	COHERENT INC COHR · Entity 125737	SaleCommon Stock	5,500	$305.80	$1,681,898.90	Disclosure SEC source: 0001179110-17-014331 · edgar.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Family Trust Disclosed balance after: 12,000 F1 · price: Represents the weighted average sales price for the shares. The range of prices for such sales was $305.76 to $306.08. The reporting person will provide upon request full information regarding the number of shares sold at each separate price. Read SEC document
November 07, 2017 Filed Nov 9, 2017 00:37 UTC	ILLUMINA, INC. ILMN · Entity 3137	Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative	20,000	$0.00 Strike: $70.82	$0.00	Disclosure SEC source: 0001127602-17-031643 · form4.xml · derivative · entry 7 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 20,000 shares Expires 2021-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document
November 07, 2017 Filed Nov 9, 2017 00:37 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	700	$212.05	$148,435.98	Disclosure SEC source: 0001127602-17-031643 · form4.xml · nonDerivative · entry 5 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 516,717 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 700 shares sold ranging from $212.03 to $212.08 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
November 07, 2017 Filed Nov 9, 2017 00:37 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	5,625	$211.46	$1,189,446.75	Disclosure SEC source: 0001127602-17-031643 · form4.xml · nonDerivative · entry 4 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 517,417 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 5,625 shares sold ranging from $211.02 to $212.01 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
November 07, 2017 Filed Nov 9, 2017 00:37 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	9,375	$210.56	$1,974,005.63	Disclosure SEC source: 0001127602-17-031643 · form4.xml · nonDerivative · entry 3 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 523,042 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 9,375 shares sold ranging from $210.01 to $210.94 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
November 07, 2017 Filed Nov 9, 2017 00:37 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	4,300	$209.27	$899,860.57	Disclosure SEC source: 0001127602-17-031643 · form4.xml · nonDerivative · entry 2 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 532,417 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 4,300 shares sold ranging from $208.84 to $209.71 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
November 07, 2017 Filed Nov 9, 2017 00:37 UTC	ILLUMINA, INC. ILMN · Entity 3137	Exercise / conversionCommon Stock	20,000	$70.82	$1,416,400.00	Disclosure SEC source: 0001127602-17-031643 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document
November 06, 2017 Filed Nov 8, 2017 01:52 UTC	ILLUMINA, INC. ILMN · Entity 3137	Tax withholdingCommon Stock	2,459	$209.19	$514,398.21	Disclosure SEC source: 0001127602-17-031551 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 516,717 Read SEC document
October 24, 2017 Filed Oct 26, 2017 22:51 UTC	ILLUMINA, INC. ILMN · Entity 3137	Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative	20,000	$0.00 Strike: $70.82	$0.00	Disclosure SEC source: 0001127602-17-030354 · form4.xml · derivative · entry 7 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 20,000 shares Expires 2021-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document
October 24, 2017 Filed Oct 26, 2017 22:51 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	309	$211.42	$65,328.69	Disclosure SEC source: 0001127602-17-030354 · form4.xml · nonDerivative · entry 5 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,176 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 309 shares sold ranging from $211.40 to $211.43 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
October 24, 2017 Filed Oct 26, 2017 22:51 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	13,325	$210.74	$2,808,061.20	Disclosure SEC source: 0001127602-17-030354 · form4.xml · nonDerivative · entry 4 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,485 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 13,325 shares sold ranging from $210.38 to $211.37 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
October 24, 2017 Filed Oct 26, 2017 22:51 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	5,066	$210.05	$1,064,094.05	Disclosure SEC source: 0001127602-17-030354 · form4.xml · nonDerivative · entry 3 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 532,810 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 5,066 shares sold ranging from $209.38 to $210.36 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
October 24, 2017 Filed Oct 26, 2017 22:51 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	1,300	$208.53	$271,084.06	Disclosure SEC source: 0001127602-17-030354 · form4.xml · nonDerivative · entry 2 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 537,876 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 1,300 shares sold ranging from $208.09 to $208.85 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
October 24, 2017 Filed Oct 26, 2017 22:51 UTC	ILLUMINA, INC. ILMN · Entity 3137	Exercise / conversionCommon Stock	20,000	$70.82	$1,416,400.00	Disclosure SEC source: 0001127602-17-030354 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document
October 10, 2017 Filed Oct 12, 2017 23:20 UTC	ILLUMINA, INC. ILMN · Entity 3137	Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative	20,000	$0.00 Strike: $70.82	$0.00	Disclosure SEC source: 0001127602-17-029793 · form4.xml · derivative · entry 6 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 20,000 shares Expires 2021-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document
October 10, 2017 Filed Oct 12, 2017 23:20 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	600	$204.29	$122,571.00	Disclosure SEC source: 0001127602-17-029793 · form4.xml · nonDerivative · entry 4 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,176 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 600 shares sold ranging from $204.22 to $204.39 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
October 10, 2017 Filed Oct 12, 2017 23:20 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	10,374	$203.78	$2,113,976.37	Disclosure SEC source: 0001127602-17-029793 · form4.xml · nonDerivative · entry 3 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,776 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 10,374 shares sold ranging from $203.11 to $204.08 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
October 10, 2017 Filed Oct 12, 2017 23:20 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	9,026	$202.62	$1,828,838.19	Disclosure SEC source: 0001127602-17-029793 · form4.xml · nonDerivative · entry 2 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 530,150 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 9,026 shares sold ranging from $202.11 to $203.09 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
October 10, 2017 Filed Oct 12, 2017 23:20 UTC	ILLUMINA, INC. ILMN · Entity 3137	Exercise / conversionCommon Stock	20,000	$70.82	$1,416,400.00	Disclosure SEC source: 0001127602-17-029793 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document
September 26, 2017 Filed Sep 28, 2017 23:01 UTC	ILLUMINA, INC. ILMN · Entity 3137	Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative	20,000	$0.00 Strike: $70.82	$0.00	Disclosure SEC source: 0001127602-17-028350 · form4.xml · derivative · entry 8 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 20,000 shares Expires 2021-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document
September 26, 2017 Filed Sep 28, 2017 23:01 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	1,224	$202.16	$247,438.82	Disclosure SEC source: 0001127602-17-028350 · form4.xml · nonDerivative · entry 6 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,176 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F6 · price: Weighted average sale price representing 1,224 shares sold ranging from $202.11 to $202.16 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
September 26, 2017 Filed Sep 28, 2017 23:01 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	6,700	$201.40	$1,349,400.10	Disclosure SEC source: 0001127602-17-028350 · form4.xml · nonDerivative · entry 5 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520,400 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 6,700 shares sold ranging from $201.06 to $202.02 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
September 26, 2017 Filed Sep 28, 2017 23:01 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	4,928	$200.67	$988,916.05	Disclosure SEC source: 0001127602-17-028350 · form4.xml · nonDerivative · entry 4 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 527,100 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 4,928 shares sold ranging from $200.04 to $200.96 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
September 26, 2017 Filed Sep 28, 2017 23:01 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	2,302	$198.79	$457,615.04	Disclosure SEC source: 0001127602-17-028350 · form4.xml · nonDerivative · entry 3 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 532,028 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 2,302 shares sold ranging from $198.68 to $199.29 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
September 26, 2017 Filed Sep 28, 2017 23:01 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	4,846	$198.05	$959,768.23	Disclosure SEC source: 0001127602-17-028350 · form4.xml · nonDerivative · entry 2 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 534,330 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 4,846 shares sold ranging from $197.63 to $198.59 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
September 26, 2017 Filed Sep 28, 2017 23:01 UTC	ILLUMINA, INC. ILMN · Entity 3137	Exercise / conversionCommon Stock	20,000	$70.82	$1,416,400.00	Disclosure SEC source: 0001127602-17-028350 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document
September 12, 2017 Filed Sep 14, 2017 22:08 UTC	ILLUMINA, INC. ILMN · Entity 3137	Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative	20,000	$0.00 Strike: $70.82	$0.00	Disclosure SEC source: 0001127602-17-027448 · form4.xml · derivative · entry 7 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 20,000 shares Expires 2021-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document
September 12, 2017 Filed Sep 14, 2017 22:08 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	700	$213.30	$149,310.98	Disclosure SEC source: 0001127602-17-027448 · form4.xml · nonDerivative · entry 5 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,176 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 700 shares sold ranging from $213.29 to $213.31 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
September 12, 2017 Filed Sep 14, 2017 22:08 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	900	$212.39	$191,149.02	Disclosure SEC source: 0001127602-17-027448 · form4.xml · nonDerivative · entry 4 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,876 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 900 shares sold ranging from $211.92 to $212.68 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
September 12, 2017 Filed Sep 14, 2017 22:08 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	12,090	$211.20	$2,553,383.82	Disclosure SEC source: 0001127602-17-027448 · form4.xml · nonDerivative · entry 3 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520,776 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 12,090 shares sold ranging from $210.88 to $211.87 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
September 12, 2017 Filed Sep 14, 2017 22:08 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	6,310	$210.50	$1,328,277.09	Disclosure SEC source: 0001127602-17-027448 · form4.xml · nonDerivative · entry 2 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 532,866 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 6,310 shares sold ranging from $209.86 to $210.84 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
September 12, 2017 Filed Sep 14, 2017 22:08 UTC	ILLUMINA, INC. ILMN · Entity 3137	Exercise / conversionCommon Stock	20,000	$70.82	$1,416,400.00	Disclosure SEC source: 0001127602-17-027448 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document
August 29, 2017 Filed Aug 30, 2017 23:58 UTC	ILLUMINA, INC. ILMN · Entity 3137	Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative	20,000	$0.00 Strike: $70.82	$0.00	Disclosure SEC source: 0001127602-17-026740 · form4.xml · derivative · entry 7 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 20,000 shares Expires 2021-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document
August 29, 2017 Filed Aug 30, 2017 23:58 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	300	$195.77	$58,731.00	Disclosure SEC source: 0001127602-17-026740 · form4.xml · nonDerivative · entry 6 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,176 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document
August 29, 2017 Filed Aug 30, 2017 23:58 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	15,636	$195.09	$3,050,427.24	Disclosure SEC source: 0001127602-17-026740 · form4.xml · nonDerivative · entry 5 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,476 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 15,636 shares sold ranging from $194.66 to $195.46 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
August 29, 2017 Filed Aug 30, 2017 23:58 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	4,064	$194.28	$789,533.60	Disclosure SEC source: 0001127602-17-026740 · form4.xml · nonDerivative · entry 4 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535,112 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 4,064 shares sold ranging from $193.64 to $194.63 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document
August 29, 2017 Filed Aug 30, 2017 23:58 UTC	ILLUMINA, INC. ILMN · Entity 3137	Exercise / conversionCommon Stock	20,000	$70.82	$1,416,400.00	Disclosure SEC source: 0001127602-17-026740 · form4.xml · nonDerivative · entry 3 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document
August 28, 2017 Filed Aug 30, 2017 23:58 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	1,270	$197.41	$250,705.37	Disclosure SEC source: 0001127602-17-026740 · form4.xml · nonDerivative · entry 2 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughters Disclosed balance after: 140 Read SEC document
August 28, 2017 Filed Aug 30, 2017 23:58 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	1,270	$197.37	$250,664.98	Disclosure SEC source: 0001127602-17-026740 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughters Disclosed balance after: 1,410 Read SEC document
August 15, 2017 Filed Aug 18, 2017 01:23 UTC	ILLUMINA, INC. ILMN · Entity 3137	Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative	20,000	$0.00 Strike: $70.82	$0.00	Disclosure SEC source: 0001127602-17-025991 · form4.xml · derivative · entry 5 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 20,000 shares Expires 2021-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document
August 15, 2017 Filed Aug 18, 2017 01:23 UTC	ILLUMINA, INC. ILMN · Entity 3137	SaleCommon Stock	1,300	$195.57	$254,234.50	Disclosure SEC source: 0001127602-17-025991 · form4.xml · nonDerivative · entry 3 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,176 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 1,300 shares sold ranging from $195.39 to $195.76 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.